Ayurcann Holdings Corp., a Canadian cannabis extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to announce that it has entered into a patient-referral agreement with ReLeave Therapeutics, leaders in providing Canadians expert guidance and access to managing discomfort with medicinal cannabis and other alternative medicines.
ReLeave, is comprised of compassionate and knowledgeable experts whose goal is defined by providing exemplary patient care, which necessitates working with only the best healthcare partners. They help integrate cannabis into the patient’s full medical treatment plans and partner with medicinal cannabis providers such as Ayurcann, to ensure their patients are getting top-quality advice with exceptional value and are being prescribed the right medicinal cannabis products for their needs.
The terms of the agreement will see ReLeave send medical cannabis patients to Ayurcann through a patient education agreement. Ayurcann will work with the patients to educate them on their available offerings and help them select appropriate products.
“Working with the leaders in the industry is what we strive towards, being able to partner with and enhance cannabis education, provide the best possible value, national coverage, while expending our offerings for the best national and international brands for THC and CBD based products to patients is making Ayurcann and Ayurcann marketplace a leader in the industry” commented Igal Sudman, CEO of Ayurcann.”
“ReLeave started at a very uncertain time, which provided us with the opportunity to provide healthcare differently and in a more patient centric way. As the world around us changes we strive to be leaders and innovators in providing patient care and working with Ayurcann and the Ayurcann Marketplace platform will enable us to excel. commented Greg Benson, CEO.”
About Ayurcann Holdings Corp.
Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma grade products for the adult use and medical cannabis industry in Canada. Ayurcann is focused on becoming the partner of choice for leading Canadian cannabis brands by providing best-in-class, proprietary services including ethanol extraction, formulation, product development and custom manufacturing.
About ReLeave Therapeutics
ReLeave is a team of people who have been in the medical cannabis field since the beginning. We are comprised of compassionate and knowledgeable experts whose goal is to help people. The ReLeave team supports our physicians with patient intake, follow up and education. We help integrate cannabis into the patient’s full medical treatment plan by working directly with the patients’ existing healthcare professionals. We believe teamwork leads to better health outcomes, and building a practice based on physician referrals allows us to work with the patients’ primary care physician more effectively.